Global Health Data Exchange - Discover the World's Health Data

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)

Nav

General Info
Geography 
Argentina (ARG)
Australia (AUS)
Austria (AUT)
Belgium (BEL)
Brazil (BRA)
Canada (CAN)
Czechia (CZE)
Denmark (DNK)
France (FRA)
Germany (DEU)
Hungary (HUN)
Ireland (IRL)
Italy (ITA)
Norway (NOR)
Poland (POL)
Russia (RUS)
Slovakia (SVK)
Spain (ESP)
Sweden (SWE)
East of England, Northern Ireland, Scotland
Alabama
Time period covered 
01/1998 - 12/2003
Citation
Authors 
McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, Køber L, Van de Werf F, Califf R, Pfeffer M
Journal 
J Am Coll Cardiol
Volume 
47
Issue 
4
Pages 
726–33
Publication year 
2006
Suggested citation 
McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, Køber L, Van de Werf F, Califf R, Pfeffer M. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). J Am Coll Cardiol. 2006; 47(4): 726–33.